IL227295A0 - Diagnostic method - Google Patents

Diagnostic method

Info

Publication number
IL227295A0
IL227295A0 IL227295A IL22729513A IL227295A0 IL 227295 A0 IL227295 A0 IL 227295A0 IL 227295 A IL227295 A IL 227295A IL 22729513 A IL22729513 A IL 22729513A IL 227295 A0 IL227295 A0 IL 227295A0
Authority
IL
Israel
Prior art keywords
diagnostic method
diagnostic
Prior art date
Application number
IL227295A
Other languages
English (en)
Hebrew (he)
Original Assignee
Cytosystems Ltd Gb
David Galloway
Nick Coleman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytosystems Ltd Gb, David Galloway, Nick Coleman filed Critical Cytosystems Ltd Gb
Publication of IL227295A0 publication Critical patent/IL227295A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G01N33/57557
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL227295A 2011-01-07 2013-07-02 Diagnostic method IL227295A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1100223.5A GB201100223D0 (en) 2011-01-07 2011-01-07 Diagnostic method
PCT/GB2012/000008 WO2012093251A1 (en) 2011-01-07 2012-01-06 Diagnostic method

Publications (1)

Publication Number Publication Date
IL227295A0 true IL227295A0 (en) 2013-09-30

Family

ID=43663908

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227295A IL227295A0 (en) 2011-01-07 2013-07-02 Diagnostic method

Country Status (8)

Country Link
US (1) US10107814B2 (enExample)
EP (2) EP2661628B1 (enExample)
JP (1) JP2014501929A (enExample)
AU (1) AU2012204796A1 (enExample)
CA (1) CA2823460A1 (enExample)
GB (1) GB201100223D0 (enExample)
IL (1) IL227295A0 (enExample)
WO (1) WO2012093251A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11054426B2 (en) * 2011-01-07 2021-07-06 Cytosystems Ltd Diagnostic method
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
EP3304082B1 (en) 2015-06-08 2020-05-13 Arquer Diagnostics Limited Methods for analysing a urine sample
GB201511196D0 (en) 2015-06-25 2015-08-12 Cytosystems Ltd Monoclonal antibodies
US20230204582A1 (en) * 2020-05-28 2023-06-29 Cytobay Inc. Cytopathological staining
WO2022064422A1 (en) * 2020-09-24 2022-03-31 Cytosystems Limited Diagnosis of cancer by imaging flow cytometry

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303323B1 (en) * 1997-10-21 2001-10-16 Cancer Research Campaign Technology Limited Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies
WO2006116327A1 (en) * 2005-04-21 2006-11-02 California Institute Of Technology Uses of parylene membrane filters

Also Published As

Publication number Publication date
CA2823460A1 (en) 2012-07-12
US20130059930A1 (en) 2013-03-07
US10107814B2 (en) 2018-10-23
GB201100223D0 (en) 2011-02-23
EP2661628B1 (en) 2016-12-21
WO2012093251A1 (en) 2012-07-12
EP2661628A1 (en) 2013-11-13
EP3214445B1 (en) 2018-11-14
EP3214445A1 (en) 2017-09-06
AU2012204796A1 (en) 2013-08-01
JP2014501929A (ja) 2014-01-23

Similar Documents

Publication Publication Date Title
DK2776833T3 (da) Cobinder-understøttet testfremgangsmåde
BR112012015988A2 (pt) método
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
BR112014002399A2 (pt) conjunto
BR112014009795A2 (pt) método
BR112014007958A2 (pt) método
EP2715659A4 (en) ABOUT FEED
BR112014001851A2 (pt) método
DK2732131T3 (da) Positioneringsfremgangsmåde
BR112014001237A2 (pt) método
DK2769050T3 (da) Propsensor
DE102011100082A8 (de) Traygreifvorrichtung
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
EP2701512A4 (en) Aldosterone synthase inhibitors
CO6960543A2 (es) 2-tiopirimidinonas
BR112013022820A2 (pt) método de tratamento
EP2723481A4 (en) FLOW COMPENSATOR
BR112013009024A2 (pt) método
BR112012023891A2 (pt) método
DK3141251T3 (da) Koloskopi - forberedelse
EP2530464A4 (en) METHOD FOR MEASURING -AMYLOID
EP2708561A4 (en) BIO-PIN
AP2013007084A0 (en) Diagnostic method
IL227295A0 (en) Diagnostic method